In the matter of Pan Pharmaceuticals Limited [2003] FCA 598

In the matter of Pan Pharmaceuticals Limited [2003] FCA 598

Given the detailed and largely uncontested evidence of the complexity and unique circumstances of the VA companies' administration, including the scale of the product recall, the volume and size of potential creditor claims, and the ongoing issues with the TGA and manufacturing licence, a 75-day extension is required to provide creditors with the information necessary to make an informed decision as envisaged by the Act.

Parties
Applicants: Anthony Gregory McGrath and Christopher John Honey (as joint administrators of Pan Pharmaceuticals Limited (Administrators Appointed) and of subsidiaries); Subject Companies: Pan Pharmaceuticals Limited (Administrators Appointed) (ACN 091 032 914) and subsidiaries as listed; Objector/director/contributory: James Selim
Jurisdiction
Australia
Judgment Date
06 June 2003
Procedural Posture
Corporations – Voluntary Administration / Application for Extension of Convening Period for Second Meeting of Creditors Under S 439 a
Outcome
Application granted
Legal Topics
Voluntary Administration, Extension of Convening Period, Meetings of Creditors, Powers of Administrators

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 6 Party arguments 2 Amounts and remedies 14
Sign in to unlock

Parties

Anthony Gregory McGrath and Christopher John Honey (as joint administrators of Pan Pharmaceuticals Limited (Administrators Appointed) and of subsidiaries)

Applicants

Pan Pharmaceuticals Limited (Administrators Appointed) (ACN 091 032 914) and subsidiaries as listed

Subject Companies

James Selim

Objector/director/contributory

Procedural Posture

Corporations – Voluntary Administration / Application for Extension of Convening Period for Second Meeting of Creditors Under S 439 a

  1. 1 Whether to extend the convening period for the second meeting of creditors pursuant to s 439A(6) of the Corporations Act 2001 (Cth)
  2. 2 Whether it is preferable for the administrators to seek additional time now or for creditors to make that decision at a meeting adjourned under the Act

Ratio Decidendi

Given the detailed and largely uncontested evidence of the complexity and unique circumstances of the VA companies' administration, including the scale of the product recall, the volume and size of potential creditor claims, and the ongoing issues with the TGA and manufacturing licence, a 75-day extension is required to provide creditors with the information necessary to make an informed decision as envisaged by the Act.

Court Disposition

Application granted

Orders

  • Extension of the convening period for the meetings of creditors under s 439A of the Corporations Act 2001 (Cth) with respect to Pan Pharmaceuticals Limited (Administrators Appointed) ACN 091 032 914; Pan Pharmaceuticals Export Pty Limited (Administrators Appointed) ACN 100 897 514; Pan Laboratories (Australia) Pty...